In patients with HF with reduced ejection fraction, the addition of an angiotensin converting enzyme (ACE) inhibitor to conventional therapy has been shown to reduce the incidence of CHF decompensation and HF-related hospitalization39. The gene discussed is ACE; the disease is hydrops fetalis.